Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association
Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association, Published online: 20 June 2018; doi:10.1038/s41375-018-0165-2Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association (Source: Leukemia)
Source: Leukemia - June 20, 2018 Category: Hematology Authors: Claudia Gebhard Dagmar Glatz Lucia Schwarzfischer Julia Wimmer Sebastian Stasik Margit Nuetzel Daniel Heudobler Reinhard Andreesen Gerhard Ehninger Christian Thiede Michael Rehli Source Type: research

Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche
Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche, Published online: 20 June 2018; doi:10.1038/s41375-018-0161-6Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche (Source: Leukemia)
Source: Leukemia - June 20, 2018 Category: Hematology Authors: Shokichi Tsukamoto Marianne B. L øvendorf Jihye Park Karma Z. Salem Michaela R. Reagan Salomon Manier Oksana Zavidij Mahshid Rahmat Daisy Huynh Satoshi Takagi Yawara Kawano Katsutoshi Kokubun Charlotte Alb æk Thrue Kenichi Nagano Andreas Petri Aldo M. R Source Type: research

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial, Published online: 20 June 2018; doi:10.1038/s41375-018-0179-9Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (Source: Leukemia)
Source: Leukemia - June 20, 2018 Category: Hematology Authors: Meinolf Suttorp Philipp Schulze Ingmar Glauche Gudrun G öhring Nils von Neuhoff Markus Metzler Petr Sedlacek Eveline S. J. M. de Bont Adriana Balduzzi Birgitte Lausen Olga Aleinikova Sabina Sufliarska G ünter Henze Gabriele Strauss Angelika Eggert Bernh Source Type: research

Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice
Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice, Published online: 20 June 2018; doi:10.1038/s41375-018-0166-1Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice (Source: Leukemia)
Source: Leukemia - June 20, 2018 Category: Hematology Authors: Jennifer Fraszczak Charles Vadnais Marissa Rashkovan Julie Ross Hugues Beauchemin Riyan Chen Damien Grapton Cyrus Khandanpour Tarik M öröy Source Type: research

Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials, Published online: 20 June 2018; doi:10.1038/s41375-018-0163-4Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials (Source: Leukemia)
Source: Leukemia - June 20, 2018 Category: Hematology Authors: Jennifer L. J. Heaney John P. Campbell Gulnaz Iqbal David Cairns Alex Richter J. Anthony Child Walter Gregory Graham Jackson Martin Kaiser Roger Owen Faith Davies Gareth Morgan Janet Dunn Mark T. Drayson Source Type: research

Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML
Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML, Published online: 20 June 2018; doi:10.1038/s41375-018-0175-0Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML (Source: Leukemia)
Source: Leukemia - June 20, 2018 Category: Hematology Authors: Oscar Br ück Sami Blom Olli Dufva Riku Turkki Himanshu Chheda Antonio Ribeiro Panu Kovanen Tero Aittokallio Perttu Koskenvesa Olli Kallioniemi Kimmo Porkka Teijo Pellinen Satu Mustjoki Source Type: research

Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo
Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo, Published online: 20 June 2018; doi:10.1038/s41375-018-0160-7Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo (Source: Leukemia)
Source: Leukemia - June 20, 2018 Category: Hematology Authors: Viktor Schneidt Marta Ilecka Peter Dreger Dwain G. van Zyl Susanne Fink Josef Mautner Henri-Jacques Delecluse Source Type: research

Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide
Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide, Published online: 15 June 2018; doi:10.1038/s41375-018-0170-5Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide (Source: Leukemia)
Source: Leukemia - June 15, 2018 Category: Hematology Authors: Avichai Shimoni Myriam Labopin Francesca Lorentino Maria Teresa Van Lint Yener Koc Zafer G ülbas Johanna Tischer Benedetto Bruno Didier Blaise Pietro Pioltelli Boris Afanasyev Fabio Ciceri Mohamad Mohty Arnon Nagler Source Type: research

ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF
ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF, Published online: 15 June 2018; doi:10.1038/s41375-018-0159-0ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF (Source: Leukemia)
Source: Leukemia - June 15, 2018 Category: Hematology Authors: Ioanna Triviai Silke Zeschke Jan Rentel Marios Spanakis Theo Scherer Razif Gabdoulline Victoria Panagiota Felicitas Thol Michael Heuser Carol Stocking Nicolaus Kr öger Source Type: research

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia
Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia, Published online: 13 June 2018; doi:10.1038/s41375-018-0157-2Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia (Source: Leukemia)
Source: Leukemia - June 13, 2018 Category: Hematology Authors: Thomas Ernst Melinda Busch Jenny Rinke Jana Ernst Claudia Haferlach James F. Beck Andreas Hochhaus Bernd Gruhn Source Type: research

Multiple myeloma clonal evolution in homogeneously treated patients
Multiple myeloma clonal evolution in homogeneously treated patients, Published online: 12 June 2018; doi:10.1038/s41375-018-0153-6Multiple myeloma clonal evolution in homogeneously treated patients (Source: Leukemia)
Source: Leukemia - June 12, 2018 Category: Hematology Authors: Jill Corre Alice Cleynen S ébastien Robiou du Pont Laure Buisson Niccolo Bolli Michel Attal Nikhil Munshi Herv é Avet-Loiseau Source Type: research

Correction: A human bone marrow mesodermal-derived cell population with hemogenic potential
Correction: A human bone marrow mesodermal-derived cell population with hemogenic potential, Published online: 11 June 2018; doi:10.1038/s41375-018-0172-3Correction: A human bone marrow mesodermal-derived cell population with hemogenic potential (Source: Leukemia)
Source: Leukemia - June 11, 2018 Category: Hematology Authors: Saloomeh Mokhtari Evan Colletti Weihong Yin Chad Sanada Zanetta Lamar Paul J. Simmons Steven Walker Colin Bishop Anthony Atala Esmail D. Zanjani Christopher D. Porada Gra ça Almeida-Porada Source Type: research

Response kinetics and factors predicting survival in core-binding factor leukemia
Response kinetics and factors predicting survival in core-binding factor leukemia, Published online: 08 June 2018; doi:10.1038/s41375-018-0158-1Response kinetics and factors predicting survival in core-binding factor leukemia (Source: Leukemia)
Source: Leukemia - June 8, 2018 Category: Hematology Authors: Prajwal Boddu Christopher Gurguis David Sanford Jorge Cortes Mary Akosile Farhad Ravandi Guillermo Garcia-Manero Keyur P Patel Tapan Kadia Mark Brandt Rita Maduike Hagop Kantarjian Gautam Borthakur Source Type: research

Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia
Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia, Published online: 08 June 2018; doi:10.1038/s41375-018-0174-1Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia (Source: Leukemia)
Source: Leukemia - June 8, 2018 Category: Hematology Authors: Seth P. Boudreaux Ryan P. Duren Steven G. Call Loc Nguyen Pablo R. Freire Padmini Narayanan Michele S. Redell Orla M. Conneely Source Type: research

Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia
Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia, Published online: 08 June 2018; doi:10.1038/s41375-018-0167-0Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia (Source: Leukemia)
Source: Leukemia - June 8, 2018 Category: Hematology Authors: Samir H. Barghout Parasvi S. Patel Xiaoming Wang G. Wei Xu Simon Kavanagh Ondrej Halgas Sara F. Zarabi Marcela Gronda Rose Hurren Danny V. Jeyaraju Neil MacLean Shawn Brennan Marc L. Hyer Allison Berger Tary Traore Michael Milhollen Adam C. Smith Mark D. Source Type: research

Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells
Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells, Published online: 08 June 2018; doi:10.1038/s41375-018-0169-yMutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells (Source: Leukemia)
Source: Leukemia - June 8, 2018 Category: Hematology Authors: Sarah K. Tasian Jessica A. Casas David Posocco Shilpa Gandre-Babbe Alyssa L. Gagne Ge Liang Mignon L. Loh Mitchell J. Weiss Deborah L. French Stella T. Chou Source Type: research

Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy
Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy, Published online: 08 June 2018; doi:10.1038/s41375-018-0162-5Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy (Source: Leukemia)
Source: Leukemia - June 8, 2018 Category: Hematology Authors: N. Timilshina H. Breunis G. A. Tomlinson J. M. Brandwein R. Buckstein S. Durbano S. M. H. Alibhai Source Type: research

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial
A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial, Published online: 06 June 2018; doi:10.1038/s41375-018-0148-3A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial (Source: Leukemia)
Source: Leukemia - June 6, 2018 Category: Hematology Authors: A K Burnett R K Hills O J Nielsen S Freeman A Ali P Cahalin A Hunter I F Thomas N H Russell Source Type: research

New drugs in AML: uses and abuses
New drugs in AML: uses and abuses, Published online: 06 June 2018; doi:10.1038/s41375-018-0168-zNew drugs in AML: uses and abuses (Source: Leukemia)
Source: Leukemia - June 6, 2018 Category: Hematology Authors: Elihu H. Estey Robert Peter Gale Mikkael A. Sekeres Source Type: research

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome, Published online: 05 June 2018; doi:10.1038/s41375-018-0147-4NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome (Source: Leukemia)
Source: Leukemia - June 5, 2018 Category: Hematology Authors: Ann-Kathrin Eisfeld Jessica Kohlschmidt Krzysztof Mr ózek Alice Mims Christopher J. Walker James S. Blachly Deedra Nicolet Shelley Orwick Sophia E. Maharry Andrew J. Carroll Bayard L. Powell Jonathan E. Kolitz Eunice S. Wang Richard M. Stone Albert de la Source Type: research

SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells
SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells, Published online: 01 June 2018; doi:10.1038/s41375-018-0152-7SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells (Source: Leukemia)
Source: Leukemia - June 1, 2018 Category: Hematology Authors: Yang Liang Toma Tebaldi Kai Rejeski Poorval Joshi Giovanni Stefani Ashley Taylor Yuanbin Song Radovan Vasic Jamie Maziarz Kunthavai Balasubramanian Anastasia Ardasheva Alicia Ding Alessandro Quattrone Stephanie Halene Source Type: research

Response to 'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression'
Response to 'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression', Published online: 25 May 2018; doi:10.1038/s41375-018-0155-4Response to 'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression' (Source: Leukemia)
Source: Leukemia - May 25, 2018 Category: Hematology Authors: Arjun Lakshman Praful Ravi S. Vincent Rajkumar Shaji K. Kumar Source Type: research

Consequences of mutant TET2 on clonality and subclonal hierarchy
Consequences of mutant TET2 on clonality and subclonal hierarchy, Published online: 24 May 2018; doi:10.1038/s41375-018-0150-9Consequences of mutant TET2 on clonality and subclonal hierarchy (Source: Leukemia)
Source: Leukemia - May 24, 2018 Category: Hematology Authors: Cassandra M. Hirsch Aziz Nazha Kassy Kneen Mohamed E. Abazeed Manja Meggendorfer Bartlomiej P. Przychodzen Niroshan Nadarajah Vera Adema Yasunobu Nagata Abhinav Goyal Hassan Awada Mohammad Fahad Asad Valeria Visconte Yihong Guan Mikkael A. Sekeres Ryszard Source Type: research

Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014
Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014, Published online: 24 May 2018; doi:10.1038/s41375-018-0149-2Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014 (Source: Leukemia)
Source: Leukemia - May 24, 2018 Category: Hematology Authors: Jop C. Teepen Rochelle E. Curtis Gra ça M. Dores Amy Berrington de Gonzalez Marry M. van den Heuvel-Eibrink Leontien C. M. Kremer Ethel S. Gilbert Flora E. van Leeuwen C écile M. Ronckers Lindsay M. Morton Source Type: research

Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response
Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response, Published online: 23 May 2018; doi:10.1038/s41375-018-0154-5Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response (Source: Leukemia)
Source: Leukemia - May 23, 2018 Category: Hematology Authors: Kana Sakamoto Ryohei Katayama Reimi Asaka Seiji Sakata Satoko Baba Hideki Nakasone Sumie Koike Naoko Tsuyama Akito Dobashi Makoto Sasaki Ryo Ichinohasama Emi Takakuwa Rie Yamazaki Jun Takizawa Takahiro Maeda Miwako Narita Koji Izutsu Yoshinobu Kanda Koich Source Type: research

The pattern of the M-protein in smoldering myeloma over the time: an evolving risk factor
The pattern of the M-protein in smoldering myeloma over the time: an evolving risk factor, Published online: 23 May 2018; doi:10.1038/s41375-018-0156-3The pattern of the M-protein in smoldering myeloma over the time: an evolving risk factor (Source: Leukemia)
Source: Leukemia - May 23, 2018 Category: Hematology Authors: Carlos Fern ández de Larrea Ignacio Isola Arturo Pereira Ma Teresa Cibeira Joan Blad é Laura Rosi ñol Source Type: research

Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease
Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease, Published online: 22 May 2018; doi:10.1038/s41375-018-0151-8Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease (Source: Leukemia)
Source: Leukemia - May 22, 2018 Category: Hematology Authors: YongHwan Kim Hye Jin Jin Jinbeom Heo Hyein Ju Hye-Yeon Lee Sujin Kim Seungun Lee Jisun Lim Sang Young Jeong JiHye Kwon Miyeon Kim Soo Jin Choi Wonil Oh Yoon Sun Yang Hyun Ho Hwang Hwan Yeul Yu Chae-Min Ryu Hong Bae Jeon Dong-Myung Shin Source Type: research

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups, Published online: 22 May 2018; doi:10.1038/s41375-018-0037-9Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups (Source: Leukemia)
Source: Leukemia - May 22, 2018 Category: Hematology Authors: Niccolo Bolli Giulia Biancon Matahi Moarii Silvia Gimondi Yilong Li Chiara de Philippis Francesco Maura Vijitha Sathiaseelan Yu-Tzu Tai Laura Mudie Sarah O ’Meara Keiran Raine Jon W. Teague Adam P. Butler Cristiana Carniti Moritz Gerstung Tina Bagratuni Source Type: research

New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment
New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment, Published online: 08 May 2018; doi:10.1038/s41375-018-0144-7New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment (Source: Leukemia)
Source: Leukemia - May 8, 2018 Category: Hematology Authors: Laurence C. Cheung Jennifer Tickner Anastasia M. Hughes Patrycja Skut Meegan Howlett Bree Foley Joyce Oommen Julia E. Wells Bo He Sajla Singh Grace-Alyssa Chua Jette Ford Charles G. Mullighan Rishi S. Kotecha Ursula R. Kees Source Type: research

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network, Published online: 02 May 2018; doi:10.1038/s41375-018-0040-1Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network (Source: Leukemia)
Source: Leukemia - May 2, 2018 Category: Hematology Authors: Heinz Ludwig Michel Delforge Thierry Facon Hermann Einsele Francesca Gay Philippe Moreau Herv é Avet-Loiseau Mario Boccadoro Roman Hajek Mohamad Mohty Michele Cavo Meletios A Dimopoulos Jes ús F San-Miguel Evangelos Terpos Sonja Zweegman Laurent Gardere Source Type: research

Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study, Published online: 27 April 2018; doi:10.1038/s41375-018-0146-5Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study (Source: Leukemia)
Source: Leukemia - April 27, 2018 Category: Hematology Authors: Stephan Stilgenbauer Veronique Leblond Robin Fo à Sebastian B öttcher Osman Ilhan Wolfgang Knauf Eva Mikuskova Christoph Renner Eugen Tausch Dariusz Woszczyk Ekaterina Gresko Linda Lundberg Tom Moore Thea Morris Susan Robson Francesc Bosch Source Type: research

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial
A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trialA predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial, Published online: 26 April 2018; doi:10.1038/s41375-018-0133-xA predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial (Source: Leukemia)
Source: Leukemia - April 26, 2018 Category: Hematology Authors: Charles Dumontet Cyrille Hulin Meletios A. Dimopoulos Andrew Belch Angela Dispenzieri Heinz Ludwig Philippe Rodon Jan Van Droogenbroeck Lugui Qiu Michele Cavo Ann Van de Velde Juan Jos é Lahuerta Olivier Allangba Jae Hoon Lee Eileen Boyle Aurore Perrot P Source Type: research

Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases
Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases, Published online: 25 April 2018; doi:10.1038/s41375-018-0143-8Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases (Source: Leukemia)
Source: Leukemia - April 25, 2018 Category: Hematology Authors: Mrinal M. Patnaik Ana A. Pierola Rangit Vallapureddy Fevzi F. Yalniz Tapan M. Kadia Elias J. Jabbour Terra Lasho Curtis A. Hanson Rhett P. Ketterling Hagop M. Kantarjian Ayalew Tefferi Guillermo Garcia-Manero Source Type: research

Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria
Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria, Published online: 25 April 2018; doi:10.1038/s41375-018-0138-5Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria (Source: Leukemia)
Source: Leukemia - April 25, 2018 Category: Hematology Authors: Michael J. Clemente Bartlomiej Przychodzen Cassandra M. Hirsch Yasunobu Nagata Taha Bat Marcin W. Wlodarski Tomas Radivoyevitch Hideki Makishima Jaroslaw P. Maciejewski Source Type: research

UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response
UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response, Published online: 25 April 2018; doi:10.1038/s41375-018-0141-xUFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response (Source: Leukemia)
Source: Leukemia - April 25, 2018 Category: Hematology Authors: LN Huiting Y Samaha GL Zhang JE Roderick B Li NM Anderson YW Wang L Wang FJF Laroche JW Choi CT Liu MA Kelliher H Feng Source Type: research

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)
Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN), Published online: 25 April 2018; doi:10.1038/s41375-018-0142-9Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) (Source: Leukemia)
Source: Leukemia - April 25, 2018 Category: Hematology Authors: Alessandra Larocca Sandra Maria Dold Sonja Zweegman Evangelos Terpos Ralph W äsch Mattia D ’Agostino Sophia Scheubeck Hartmut Goldschmidt Francesca Gay Michele Cavo Heinz Ludwig Christian Straka Sara Bringhen Holger W. Auner Jo Caers Martin Gramatzki M Source Type: research

JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation
JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation, Published online: 24 April 2018; doi:10.1038/s41375-018-0145-6JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation (Source: Leukemia)
Source: Leukemia - April 24, 2018 Category: Hematology Authors: Wenbin Xiao Raajit Rampal Yanming Zhang Robert Cimera Achim A. Jungbluth Maria Arcila Mikhail Roshal David C. Park Source Type: research

Management of patients with acute promyelocytic leukemia
Management of patients with acute promyelocytic leukemia, Published online: 24 April 2018; doi:10.1038/s41375-018-0139-4Management of patients with acute promyelocytic leukemia (Source: Leukemia)
Source: Leukemia - April 24, 2018 Category: Hematology Authors: Sabine Kayser Richard F. Schlenk Uwe Platzbecker Source Type: research

Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS
Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS, Published online: 24 April 2018; doi:10.1038/s41375-018-0140-yDysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS (Source: Leukemia)
Source: Leukemia - April 24, 2018 Category: Hematology Authors: Nasrin Rastgoo Maryam Pourabdollah Jahangir Abdi Donna Reece Hong Chang Source Type: research

Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used
Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used, Published online: 20 April 2018; doi:10.1038/s41375-018-0041-0Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used (Source: Leukemia)
Source: Leukemia - April 20, 2018 Category: Hematology Authors: Xavier Bossuyt Michel Delforge Martin Reynders Doreen Dillaerts Ben Sprangers Karel Fostier Koen Poesen Martine Vercammen Source Type: research

Validation of the EUTOS long-term survival score in a recent independent cohort of “real world” CML patients
Validation of the EUTOS long-term survival score in a recent independent cohort of “real world” CML patientsValidation of the EUTOS long-term survival score in a recent independent cohort of “real world” CML patients, Published online: 19 April 2018; doi:10.1038/s41375-018-0136-7Validation of the EUTOS long-term survival score in a recent independent cohort of “real world” CML patients (Source: Leukemia)
Source: Leukemia - April 19, 2018 Category: Hematology Authors: Inge G. P. Geelen Fredrik Sandin Noortje Thielen Jeroen J. W. M. Janssen Mels Hoogendoorn Otto Visser Jan J. Cornelissen Martin Hoglund Peter E. Westerweel Source Type: research

GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML, Published online: 19 April 2018; doi:10.1038/s41375-018-0134-9GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML (Source: Leukemia)
Source: Leukemia - April 19, 2018 Category: Hematology Authors: Ahad F. Al Seraihi Ana Rio-Machin Kiran Tawana Csaba B ödör Jun Wang Ai Nagano James A. Heward Sameena Iqbal Steven Best Nicholas Lea Donal McLornan Emilia J. Kozyra Marcin W. Wlodarski Charlotte M. Niemeyer Hamish Scott Chris Hahn Alicia Ellison Hemant Source Type: research

Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion, Published online: 18 April 2018; doi:10.1038/s41375-018-0131-zAutocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion (Source: Leukemia)
Source: Leukemia - April 18, 2018 Category: Hematology Authors: William L. Heaton Anna V. Senina Anthony D. Pomicter Mohamed E. Salama Phillip M. Clair Dongqing Yan Russell N. Bell Jeremy M. Gililland Josef T. Prchal Thomas O ’Hare Michael W. Deininger Source Type: research

Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia
Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia, Published online: 18 April 2018; doi:10.1038/s41375-018-0127-8Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia (Source: Leukemia)
Source: Leukemia - April 18, 2018 Category: Hematology Authors: Jolien De Bie Sofie Demeyer Llucia Alberti Servera Ellen Geerdens Heidi Segers Micha ël Broux Kim De Keersmaecker Lucienne Michaux Peter Vandenberghe Thierry Voet Nancy Boeckx Anne Uyttebroeck Jan Cools Source Type: research

Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia
Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia, Published online: 18 April 2018; doi:10.1038/s41375-018-0130-0Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia (Source: Leukemia)
Source: Leukemia - April 18, 2018 Category: Hematology Authors: Elaine G. Garcia Sowmya Iyer Sara P. Garcia Siebe Loontiens Ruslan I. Sadreyev Frank Speleman David M. Langenau Source Type: research

Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia
Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia, Published online: 18 April 2018; doi:10.1038/s41375-018-0137-6Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia (Source: Leukemia)
Source: Leukemia - April 18, 2018 Category: Hematology Authors: Aline Renneville Philippe Attias Xavier Thomas C écile Bally Sandrine Hayette Hassan Farhat Virginie Eclache Alice Marceau-Renaut Bruno Cassinat Jean Feuillard Christine Terr é Eric Delabesse Sophie Park Julie Lejeune Sylvie Chevret Lionel Ad ès Claude Source Type: research

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trialAdding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial, Published online: 17 April 2018; doi:10.1038/s41375-018-0129-6Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial (Source: Leukemia)
Source: Leukemia - April 17, 2018 Category: Hematology Authors: Peter Paschka Richard F Schlenk Daniela Weber Axel Benner Lars Bullinger Michael Heuser Verena I Gaidzik Felicitas Thol Mridul Agrawal Veronica Teleanu Michael L übbert Walter Fiedler Markus Radsak J ürgen Krauter Heinz-A. Horst Richard Greil Karin Maye Source Type: research

Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies
Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies, Published online: 17 April 2018; doi:10.1038/s41375-018-0132-ySerial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies (Source: Leukemia)
Source: Leukemia - April 17, 2018 Category: Hematology Authors: Philip A. Thompson Christine B. Peterson Paolo Strati Jeff Jorgensen Michael J. Keating Susan M. O ’Brien Alessandra Ferrajoli Jan A. Burger Zeev Estrov Nitin Jain Tapan M. Kadia Gautam Borthakur Courtney D. DiNardo Naval Daver Elias Jabbour William G. Source Type: research

Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms, Published online: 17 April 2018; doi:10.1038/s41375-018-0135-8Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms (Source: Leukemia)
Source: Leukemia - April 17, 2018 Category: Hematology Authors: Anna B. Halpern Megan Othus Emily M. Huebner Bart L. Scott Pamela S. Becker Mary-Elizabeth M. Percival Paul C. Hendrie Kelda M. Gardner Tara L. Chen Sarah A. Buckley Kaysey F. Orlowski Asma Anwar Frederick R. Appelbaum Harry P. Erba Elihu H. Estey Roland Source Type: research

Constitutive activation of nuclear factor kappa B-inducing kinase counteracts apoptosis in cells with rearranged mixed lineage leukemia gene
Constitutive activation of nuclear factor kappa B-inducing kinase counteracts apoptosis in cells with rearranged mixed lineage leukemia gene, Published online: 17 April 2018; doi:10.1038/s41375-018-0128-7Constitutive activation of nuclear factor kappa B-inducing kinase counteracts apoptosis in cells with rearranged mixed lineage leukemia gene (Source: Leukemia)
Source: Leukemia - April 17, 2018 Category: Hematology Authors: Maja Studencka-Turski Gunter Maubach Michael Hartmut Feige Michael Naumann Source Type: research